این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
International Journal of Organ Transplantation Medicine، جلد ۸، شماره ۲، صفحات ۰-۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
چکیده انگلیسی مقاله Background: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. Objective: To evaluate the changes in serum soluble TNF-like weak inducer of apoptosis (sTWEAK) and fibroblast growth factor 23 (FGF-23) in hemodialysis (HD) patients and renal transplant recipients (RTR). Methods: Serum samples were obtained from 30 patients on chronic HD, 30 RTRs, and 30 normal controls. Biochemical factors, sTWEAK, FGF-23, and interleukin-6 (IL-6) were measured by standard methods. Results: Serum levels of sTWEAK in RTRs were significantly higher than those in the HD patients (p=0.025); RTR and HD patients had significantly lower sTWEAK levels than the controls (p=0.001 and p= 0.038, respectively). Serum levels of FGF-23 in HD patients were significantly (p=0.001) higher than those in the RTR; the level was higher in both studied groups compared to that in the controls (p=0.001 for both groups). The mean serum level of IL-6 in HD was significantly higher than that in RTR patients (p=0.013). IL-6 levels in both groups were significantly higher than those in controls (p=0.001 and p= 0.012, respectively). In HD group a negative correlation was found between FGF-23 and sTWEAK (r= ‑0.375, p=0.041); there were also a significant correlation between FGF-23 and IL-6 (r= 0.480, p= 0.007) and between IL-6 and sTWEAK (r= ‑0.409, p=0.025). Conclusion: We found that serum sTWEAK is decreased and FGF-23 is increased in HD and RTR groups comparing with the control group. However, further studies are needed to shed light over their direct role on atherosclerosis and cardiovascular outcomes.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | H Eskandari Naji
Department of Clinical Biochemistry and Laboratory Medicine, Tabriz University of Medical Sciences, Tabriz, Iran and Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran


| A Ghorbanihaghjo
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran


| H Argani
Department of Urology, Shahid Modarres Hospital, Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran


| S Raeisi
Division of Clinical Laboratory, Children’s Hospital, Tabriz University of Medical Sciences, Tabriz, Iran


| J Safa
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran


| AH Alirezaei
Department of Urology, Shahid Modarres Hospital, Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran


| N Rashtchizadeh
Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
نشانی اینترنتی http://www.ijotm.com/ojs/index.php/IJOTM/article/view/338
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/221/article-221-807885.pdf
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده Original Articles
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات